| 1 | [SID26670736] | Active | EC50 | 0.01406 | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26670736 | | CID | 661788 | | Outcome | Active | | EC50 | 0.01406 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 588407 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 2 | [SID26670736] | Active | EC50 | 0.01406 | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26670736 | | CID | 661788 | | Outcome | Active | | EC50 | 0.01406 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 588407 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 3 | [SID26670736] | Active | EC50 | 0.01731 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization [AID588411, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26670736 | | CID | 661788 | | Outcome | Active | | EC50 | 0.01731 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization | | AID | 588411 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 4 | [SID26670736] | Active | EC50 | 0.01731 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization [AID588411, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26670736 | | CID | 661788 | | Outcome | Active | | EC50 | 0.01731 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization | | AID | 588411 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 5 | [SID860502] | Active | EC50 | 0.1493 | Confirmation dose response assay for compounds that activate transient receptor potential cation channel C4 (TRPC4) [AID434937, Type: confirmatory] | alternatively spliced Trp4 [Mus musculus] [gi:2935630] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | EC50 | 0.1493 [uM] | | BioAssay | Confirmation dose response assay for compounds that activate transient receptor potential cation channel C4 (TRPC4) | | AID | 434937 | | BioAssay type | confirmatory | | Target | alternatively spliced Trp4 [Mus musculus] [gi:2935630] | | PubMed | | | Data Table |  |
|
| 6 | [SID860502] | Active | Potency | 0.631 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor [AID926, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | Potency | 0.631 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor | | AID | 926 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 7 | [SID860502] | Active | Potency | 0.631 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor [AID926, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | Potency | 0.631 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor | | AID | 926 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 8 | [SID860502] | Active | Potency | 0.631 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor [AID926, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | Potency | 0.631 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor | | AID | 926 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 9 | [SID860502] | Active | Potency | 0.631 | Confirmation Concentration-Response Assay for Agonists of the Thyroid Stimulating Hormone Receptor [AID939, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | Potency | 0.631 [uM] | | BioAssay | Confirmation Concentration-Response Assay for Agonists of the Thyroid Stimulating Hormone Receptor | | AID | 939 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 10 | [SID860502] | Active | Potency | 0.631 | Confirmation Concentration-Response Assay for Agonists of the Thyroid Stimulating Hormone Receptor [AID939, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | Potency | 0.631 [uM] | | BioAssay | Confirmation Concentration-Response Assay for Agonists of the Thyroid Stimulating Hormone Receptor | | AID | 939 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 11 | [SID860502] | Active | Potency | 0.631 | Confirmation Concentration-Response Assay for Agonists of the Thyroid Stimulating Hormone Receptor [AID939, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | Potency | 0.631 [uM] | | BioAssay | Confirmation Concentration-Response Assay for Agonists of the Thyroid Stimulating Hormone Receptor | | AID | 939 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 12 | [SID860502] | Active | Potency | 10.4179 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | Potency | 10.4179 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID124888752] | Active | Potency | 11.2202 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 124888752 | | CID | 661788 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 14 | [SID124888752] | Active | Potency | 11.2202 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 124888752 | | CID | 661788 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 15 | [SID124888752] | Active | Potency | 11.2202 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 124888752 | | CID | 661788 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 16 | [SID860502] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Influenza NS1 Protein Function [AID2326, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Influenza NS1 Protein Function | | AID | 2326 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] | | PubMed | | | Data Table |  |
|
| 17 | [SID860502] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) [AID887, Type: confirmatory] | 15-lipoxygenase [Homo sapiens] [gi:1832253] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) | | AID | 887 | | BioAssay type | confirmatory | | Target | 15-lipoxygenase [Homo sapiens] [gi:1832253] | | PubMed | | | Data Table |  |
|
| 18 | [SID860502] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) [AID887, Type: confirmatory] | 15-lipoxygenase [Homo sapiens] [gi:1832253] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) | | AID | 887 | | BioAssay type | confirmatory | | Target | 15-lipoxygenase [Homo sapiens] [gi:1832253] | | PubMed | | | Data Table |  |
|
| 19 | [SID57655021] | Active | Potency | 15.8489 | Secondary Concentration-Response Assay for Agonists of the Thyroid Stimulating Hormone Receptor: HTRF Activity Detection [AID933, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 57655021 | | CID | 661788 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | Secondary Concentration-Response Assay for Agonists of the Thyroid Stimulating Hormone Receptor: HTRF Activity Detection | | AID | 933 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 20 | [SID57655021] | Active | Potency | 15.8489 | Secondary Concentration-Response Assay for Agonists of the Thyroid Stimulating Hormone Receptor: HTRF Activity Detection [AID933, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 57655021 | | CID | 661788 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | Secondary Concentration-Response Assay for Agonists of the Thyroid Stimulating Hormone Receptor: HTRF Activity Detection | | AID | 933 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 21 | [SID57655021] | Active | Potency | 15.8489 | Secondary Concentration-Response Assay for Agonists of the Thyroid Stimulating Hormone Receptor: HTRF Activity Detection [AID933, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 57655021 | | CID | 661788 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | Secondary Concentration-Response Assay for Agonists of the Thyroid Stimulating Hormone Receptor: HTRF Activity Detection | | AID | 933 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 22 | [SID26670736] | Active | Potency | 31.6228 | qHTS Assay for Activators of ClpP [AID651965, Type: confirmatory] | ClpP [Bacillus subtilis] [gi:2668494] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26670736 | | CID | 661788 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Activators of ClpP | | AID | 651965 | | BioAssay type | confirmatory | | Target | ClpP [Bacillus subtilis] [gi:2668494] | | PubMed | | | Data Table |  |
|
| 23 | [SID860502] | Active | Potency | 31.6228 | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 [AID893, Type: confirmatory] | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 | | AID | 893 | | BioAssay type | confirmatory | | Target | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] | | PubMed | | | Data Table |  |
|
| 24 | [SID57655021] | Active | Potency | 89.1251 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 57655021 | | CID | 661788 | | Outcome | Active | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 25 | [SID860502] | Active | | | CYP2C19 Assay [AID778, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | BioAssay | CYP2C19 Assay | | AID | 778 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 26 | [SID860502] | Active | | | CYP2C19 Assay [AID778, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | BioAssay | CYP2C19 Assay | | AID | 778 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 27 | [SID860502] | Active | | | CYP2C9 Assay [AID777, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | BioAssay | CYP2C9 Assay | | AID | 777 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] | | PubMed | | | Data Table |  |
|
| 28 | [SID860502] | Active | | | CYP2C9 Assay [AID777, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | BioAssay | CYP2C9 Assay | | AID | 777 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] | | PubMed | | | Data Table |  |
|
| 29 | [SID860502] | Active | | | CYP2C9 Assay [AID777, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | BioAssay | CYP2C9 Assay | | AID | 777 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] | | PubMed | | | Data Table |  |
|
| 30 | [SID860502] | Active | | | Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity [AID504408, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | BioAssay | Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity | | AID | 504408 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID26670736] | Active | | | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies [AID588358, Type: screening] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26670736 | | CID | 661788 | | Outcome | Active | | BioAssay | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies | | AID | 588358 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID860502] | Active | | | Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm [AID709, Type: screening] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | BioAssay | Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm | | AID | 709 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID860502] | Active | | | qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region [AID589, Type: other] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | BioAssay | qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region | | AID | 589 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID860502] | Active | | | qHTS Assay for Spectroscopic Profiling in A350 Spectral Region [AID590, Type: other] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | BioAssay | qHTS Assay for Spectroscopic Profiling in A350 Spectral Region | | AID | 590 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID57655021] | Active | | | Quantitative High-Throughput Screen for Agonists of Thyroid Stimulating Hormone Receptor: Summary [AID1401, Type: summary] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 57655021 | | CID | 661788 | | Outcome | Active | | BioAssay | Quantitative High-Throughput Screen for Agonists of Thyroid Stimulating Hormone Receptor: Summary | | AID | 1401 | | BioAssay type | summary | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 36 | [SID57655021] | Active | | | Quantitative High-Throughput Screen for Agonists of Thyroid Stimulating Hormone Receptor: Summary [AID1401, Type: summary] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 57655021 | | CID | 661788 | | Outcome | Active | | BioAssay | Quantitative High-Throughput Screen for Agonists of Thyroid Stimulating Hormone Receptor: Summary | | AID | 1401 | | BioAssay type | summary | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 37 | [SID57655021] | Active | | | Quantitative High-Throughput Screen for Agonists of Thyroid Stimulating Hormone Receptor: Summary [AID1401, Type: summary] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 57655021 | | CID | 661788 | | Outcome | Active | | BioAssay | Quantitative High-Throughput Screen for Agonists of Thyroid Stimulating Hormone Receptor: Summary | | AID | 1401 | | BioAssay type | summary | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 38 | [SID860502] | Active | | | Specificity screen against TRPC6 for compounds that activate transient receptor potential cation channel C4 (TRPC4) [AID434950, Type: screening] | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | BioAssay | Specificity screen against TRPC6 for compounds that activate transient receptor potential cation channel C4 (TRPC4) | | AID | 434950 | | BioAssay type | screening | | Target | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] | | PubMed | | | Data Table |  |
|
| 39 | [SID860502] | Active | | | Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4). [AID2237, Type: screening] | alternatively spliced Trp4 [Mus musculus] [gi:2935630] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Active | | BioAssay | Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4). | | AID | 2237 | | BioAssay type | screening | | Target | alternatively spliced Trp4 [Mus musculus] [gi:2935630] | | PubMed | | | Data Table |  |
|
| 40 | [SID26670736] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID588726, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26670736 | | CID | 661788 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 588726 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 41 | [SID26670736] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26670736 | | CID | 661788 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 42 | [SID26670736] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26670736 | | CID | 661788 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 43 | [SID26670736] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504904, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26670736 | | CID | 661788 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504904 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 44 | [SID26670736] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504904, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26670736 | | CID | 661788 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504904 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 45 | [SID124888752] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 124888752 | | CID | 661788 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 46 | [SID124888752] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 124888752 | | CID | 661788 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 47 | [SID26670736] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26670736 | | CID | 661788 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 48 | [SID26670736] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26670736 | | CID | 661788 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 49 | [SID860502] | Inactive | Potency | 1.5849 | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a [AID927, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Inactive | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a | | AID | 927 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 50 | [SID860502] | Inactive | Potency | 1.5849 | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a [AID927, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 860502 | | CID | 661788 | | Outcome | Inactive | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a | | AID | 927 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|